Clinical Trial Update: Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether pre-treatment with rosuvastatin impacts the risk of coronary intervention in patients with coronary artery disease. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University Hospital, Motol | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN